Drug intelligence / Profile preview

hydrochlorothiazide + telmisartan

Development stage
Phase 3
Lead developer
Boehringer Ingelheim
Modality
Small Molecules
Administration
Oral
01

Overview

Hydrochlorothiazide + telmisartan is a fixed-dose combination oral medication used to treat high blood pressure (hypertension). It contains two active ingredients: - **Telmisartan**, an angiotensin II receptor blocker (ARB), which lowers blood pressure by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle and the adrenal gland. This action prevents vasoconstriction and aldosterone secretion, leading to relaxation of blood vessels and reduced blood pressure. - **Hydrochlorothiazide**, a thiazide diuretic ("water pill"), which reduces plasma volume by increasing renal excretion of sodium and chloride, thereby promoting diuresis. This also helps lower blood pressure. The combination provides greater antihypertensive efficacy than either drug alone, offers effective 24-hour control of blood pressure, and is generally well-tolerated. It is indicated for patients whose hypertension is not adequately controlled with monotherapy[1][2][3][5][6].

Brand names
Micardis HCT
Other names
telmisartan and hydrochlorothiazidetelmisartan/hydrochlorothiazideHCTZ/telmisartan
02

Targets

AGTR1 (Angiotensin II Type-1 receptor)SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)

Beyond the preview

Go deeper on hydrochlorothiazide + telmisartan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrochlorothiazide + telmisartan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call